BPro BT Ambulatory Blood Pressure Monitoring System with BProSoft BT PC Software
by Healthstats International Pte Ltd
510(k) K173028
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK173028 | Date21 Jun 2018 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- DXN
- FDA applicant
- Healthstats International Pte. , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1130
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The BPro BT Ambulatory Blood Pressure Monitoring System with BProSoft BT PC Software is a noninvasive ambulatory blood pressure monitoring device classified under product code DXN. It employs arterial tonometry at the radial artery of the wrist to measure blood pressure continuously over extended periods, providing detailed cardiovascular monitoring for clinical assessment.
This system comprises a wrist-mounted BPro BT tonometric monitor, a BPCalibrator MC3100+ oscillometric device for calibration, and BProSoft BT PC software for data analysis. Supplied as a reusable medical device, it is intended for use in clinical settings and has received FDA 510(k) clearance under Special Review, along with MDR authorization. The device requires proper storage and calibration to ensure accurate readings.
Other devices from Healthstats International Pte Ltd
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the BPro BT Ambulatory Blood Pressure Monitoring System, and how does it differ from traditional blood pressure cuffs?
The BPro BT system is designed for continuous, noninvasive ambulatory blood pressure monitoring by measuring arterial tonometry at the radial artery on the wrist. Unlike traditional cuff-based devices that take intermittent readings, this system provides detailed cardiovascular assessment over extended periods, making it ideal for tracking blood pressure trends outside of a clinical setting. It combines a wrist-mounted monitor with a calibration device (BPCalibrator MC3100+) and software for data analysis, ensuring accuracy through periodic oscillometric validation.
Is the BPro BT device single-use or reusable, and what maintenance does it require?
The BPro BT system is reusable and intended for clinical use, meaning it can be used across multiple patients with proper cleaning and maintenance. To ensure accurate readings, it requires regular calibration using the included BPCalibrator MC3100+ device. Additionally, storage conditions must be followed to preserve functionality, as the manufacturer emphasizes proper handling to maintain performance.
How does the BProSoft BT PC software factor into the device’s functionality, and what role does it play in clinical use?
The BProSoft BT PC software is a critical component of the system, as it analyzes and visualizes the continuous blood pressure data collected by the wrist-mounted monitor. Clinicians use it to interpret trends, generate reports, and assess cardiovascular health over time. The software integrates with the calibration device to validate measurements, ensuring the data remains reliable for clinical assessment.
What regulatory pathways has the BPro BT system undergone, and what does that mean for its clinical adoption?
The BPro BT system has received FDA 510(k) clearance under Special Review and MDR authorization, confirming its compliance with regulatory standards for ambulatory blood pressure monitoring. This means it has been evaluated for safety and effectiveness by the FDA and meets EU medical device regulations, providing confidence in its clinical adoption for noninvasive cardiovascular monitoring in healthcare settings.